LTLenka Tesarova

Lenka Tesarova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lenka Tesarova has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • Pavel Simara

    Centre for Biomedical Image Analysis, Faculty of Informatics, Masaryk University , Brno, Czech Republic

    2 shared publications
  • Stanislav Stejskal

    Centre for Biomedical Image Analysis, Faculty of Informatics, Masaryk University , Brno, Czech Republic

    2 shared publications
  • Irena Koutna

    Centre for Biomedical Image Analysis, Faculty of Informatics, Masaryk University, Brno, Czech Republic

    1 shared publication
  • Irena Koutna

    Centre for Biomedical Image Analysis, Faculty of Informatics, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic

    1 shared publication
  • Irena Koutna

    Centre for Biomedical Image Analysis, Faculty of Informatics, Masaryk University , Brno, Czech Republic

    1 shared publication
  • Ivan Capov

    1st Department of Surgery, St. Anne’s University Hospital Brno, Pekařská 53, 656 91 Brno, Czech Republic

    1 shared publication

Latest Publications

  • Hematopoietic Developmental Potential of Human Pluripotent Stem Cell Lines Is Accompanied by the Morphology of Embryoid Bodies and the Expression of Endodermal and Hematopoietic Markers

    by Lenka Tesarova, Pavel Simara, Stanislav Stejskal, Irena Koutna

    The potential clinical applications of hematopoietic stem cells (HSCs) derived from human pluripotent stem cells (hPSCs) are limited by the difficulty of recapitulating embryoid hematopoiesis and by the unknown differentiation potential of hPSC lines. To evaluate their hematopoietic developmental potential, available hPSC lines were differentiated by an embryoid body (EB) suspension culture in serum-free medium supplemented with three different cytokine mixes (CMs). The hPSC differentiation status was investigated by the flow cytometry expression profiles of cell surface molecules, and the gene expression of pluripotency and differentiation markers over time was evaluated by real-time reverse transcription polymerase chain reaction (qRT-PCR). hPSC lines differed in several aspects of the differentiation process, including the absolute yield of hematopoietic progenitors, the proportion of hematopoietic progenitor populations, and the effect of various CMs. The ability to generate hematopoietic progenitors was then associated with the morphology of the developing EBs, the expression of the endodermal markers AFP and SOX17, and the hematopoietic transcription factor RUNX1. These findings deepen the knowledge about the hematopoietic propensity of hPSCs and identify its variability as an aspect that must be taken into account before the usage of hPSC-derived HSCs in downstream applications.


  • Open Access

    The Aberrant DNA Methylation Profile of Human Induced Pluripotent Stem Cells Is Connected to the Reprogramming Process and Is Normalized During In Vitro Culture

    by Lenka Tesarova, Pavel Simara, Stanislav Stejskal, Irena Koutna

    The potential clinical applications of human induced pluripotent stem cells (hiPSCs) are limited by genetic and epigenetic variations among hiPSC lines and the question of their equivalency with human embryonic stem cells (hESCs). We used MethylScreen technology to determine the DNA methylation profile of pluripotency and differentiation markers in hiPSC lines from different source cell types compared to hESCs and hiPSC source cells. After derivation, hiPSC lines compromised a heterogeneous population characterized by variable levels of aberrant DNA methylation. These aberrations were induced during somatic cell reprogramming and their levels were associated with the type of hiPSC source cells. hiPSC population heterogeneity was reduced during prolonged culture and hiPSCs acquired an hESC-like methylation profile. In contrast, the expression of differentiation marker genes in hiPSC lines remained distinguishable from that in hESCs. Taken together, in vitro culture facilitates hiPSC acquisition of hESC epigenetic characteristics. However, differences remain between both pluripotent stem cell types, which must be considered before their use in downstream applications.


  • Open Access

    Intravenous insulin therapy during lung resection does not affect lung function or surfactant proteins

    by Zdenek Ručka, Irena Koutná, Lenka Tesařová, Michaela Potěšilová, Stanislav Stejskal, Pavel Šimara, Petr Vaňhara, Jan Doležel, Vaclav Zvoníček, Oldřich Coufal, et al.

    The surgical resection of lung disrupts glucose homeostasis and causes hyperglycemia, as in any other major surgery or critical illness. We performed a prospective study where we carefully lowered hyperglycemia by insulin administration during the surgery, and for the first time we monitored immediate insulin effects on lung physiology and gene transcription. The levels of blood gases (pH, pCO2, pO2, HCO3-, HCO3- std, base excess, FiO2, and pO2/FiO2) were measured at the beginning of surgery, at the end of surgery, and two hours after. Samples of healthy lung tissue surrounding the tumour were obtained during the surgery, anonymized and sent for subsequent blinded qPCR analysis (mRNA levels of surfactant proteins A1, A2, B, C and D were measured). This study was done on a cohort of 64 patients who underwent lung resection. Patients were randomly divided, and half of them received insulin treatment during the surgery. We demonstrated for the first time that insulin administered intravenously during lung resection does not affect levels of blood gases. Furthermore, it does not induce immediate changes in the expression of surfactant proteins. According to our observations, short insulin treatment applied intravenously during resection does not affect the quality of breathing.